Damien Keogh

Entrepreneur & Microbiologist | CEO & Founder at BluMaiden | Drug Discovery Platforms | Investment | Fascinated by Bacterial Communities.

[Damien Keogh @DKeo__]

Another job opening at BluMaiden - Join an exciting Biotechnology Platform Company. We work with human microbiomes and lots of data on our discovery mission for new molecular therapeutics. If you are talented and hungry for new challenges, please contact us!

[Damien Keogh @DKeo__]

Join an exciting Biotechnology Platform Company - BluMaiden is hiring. We work with human microbiomes and lots of data on our discovery mission for new molecular therapeutics. If your talented and hungry for new challenges, please contact us!

[Damien Keogh @DKeo__]

New Job Opening at BluMaiden in Singapore - Scientist (Laboratory Operations & Management) Email resume and cover letter to [email protected] See link for full details https://t.co/54nq25GuQS

[Damien Keogh @DKeo__]

Computational Biology Job Opening at BluMaiden in Singapore. Opportunity to work in the microbiome space in a biotechnology venture. Resume and cover letter to [email protected] See full details at https://t.co/psiyWznN35

[Damien Keogh @DKeo__]

Great news for Singapore Biotech & patients - Enleofen Bio announces the largest deal so far in Singapore. Their preclinical anti-fibrotic drugs targeting IL-11 will make more than $1B per drug in upfront payments and milestones to Boehringer Ingelheim. https://t.co/CHFl3XDsKk

[Damien Keogh @DKeo__]

Very happy for my former colleagues

[LKCMedicine @NTU_LKCMedicine]

Researchers from the Singapore-MIT Alliance for Research and Technology (SMART) and LKCMedicine designed a polymer that can kill bacteria resistant to commonly used antibiotics, including the superbug methicillin-resistant Staphylococcus aureus (MRSA). https://t.co/IwPdXeisIp

[Damien Keogh @DKeo__]

@swaine_chen Reimbursement is the real issue. As an entrepreneur, investors have been clear that with no buyer new antimicrobials will have no value (so no new drugs) Will be interesting to see how new payment models work out - like the antibiotics subscription-type payment trial in the UK.

[Damien Keogh @DKeo__]

Proud that Maiden Therapeutics is a resident at JLABS Shanghai. Love my trips to this city.

[JLABS @JLABS]

“China’s start-up ecosystem is booming, and the potential for innovation is enormous.” @nature’s @nresearchnews features @melindarichter, Global Head #JLABS & Sharon Chan, Head #JLABSShanghai, in an article on why Shanghai is the next innovation hotspot https://t.co/5bXfvZG5Hb

[CHARM UC San Diego @CHARM_UCSD]

Kim Lewis lab (Northeastern) finds a new antibiotic inside a bacteria inside a parasitic worm inside a caterpillar egg, and shares their findings in this week’s Nature. Darobactin has remarkable activity against high priority MDR Gram-negative bacteria https://t.co/0qtjALmydk

[Fabian A. Schmidt @3BodyProblem]

Drone Animation in #China feels like Blade Runner and Ghost In The Shell

Via @evankirstel

#Drones
https://t.co/8SSNUEm2gS

[Damien Keogh @DKeo__]

Delighted for my former colleagues getting their work published. Happy to have had the opportunity to work with them on this one....

[Damien Keogh @DKeo__]

JLABS Shanghai opening last week & our Maiden Therapeutics launch (https://t.co/t1PLLlYwy5) - I didn’t realize all had happened on #worldmicrobiomeday

[JLABS @JLABS]

Hear why we co-located the #JLABSShanghai site with our Janssen R&D site to support our commitment to help build the local innovation ecosystem in Asia. "It's great to see our dream finally become a reality." - Mark Bach, VP and Head Asia Pacific Medical Sciences, Janssen R&D

[Damien Keogh @DKeo__]

The Lion Dance at JLABS! Best of luck to the new resident companies

[Jenny @jennyoan]

JLABS @ Shanghai is officially blessed with good luck + fortune!! 🎊🌟 @chelsbells4 @beckbeck11 @DedmanJulien @SeemaJJIC @melindarichter @JLABS @JNJInnovation @JNJCares

[Damien Keogh @DKeo__]

Super exciting week in Shanghai! Officially doing business in China 😀 ..... and partying in Shanghai Tower 🤪

[Damien Keogh @DKeo__]

Such a nice crowd! Really enjoyed the A*STAR postdocs society networking event (A*PECSS M&N) this week. Thanks for the invitation, a whole lot of fun talking through my experiences and learning from others.

[Damien Keogh @DKeo__]

Had a lot of fun with this one - presenting our view of Venture Capital and Entrepreneurship alongside XQ Lin (ESCO Ventures) at SMART-MIT AMR Interdisciplinary Research Group.

[Damien Keogh @DKeo__]

Big day for us. We got a chance to pitch Maiden Therapeutics to a legend in Biotechnology - Prof Harvey Lodish, MIT Whitehead Institute. Very luck to have the opportunity to meet him @chensiyi10